These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 9233698
1. SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo. Schuler W, Sedrani R, Cottens S, Häberlin B, Schulz M, Schuurman HJ, Zenke G, Zerwes HG, Schreier MH. Transplantation; 1997 Jul 15; 64(1):36-42. PubMed ID: 9233698 [Abstract] [Full Text] [Related]
2. SDZ RAD, a new rapamycin derivative: synergism with cyclosporine. Schuurman HJ, Cottens S, Fuchs S, Joergensen J, Meerloo T, Sedrani R, Tanner M, Zenke G, Schuler W. Transplantation; 1997 Jul 15; 64(1):32-5. PubMed ID: 9233697 [Abstract] [Full Text] [Related]
3. SDZ-RAD prevents manifestation of chronic rejection in rat renal allografts. Viklický O, Zou H, Müller V, Lacha J, Szabó A, Heemann U. Transplantation; 2000 Feb 27; 69(4):497-502. PubMed ID: 10708101 [Abstract] [Full Text] [Related]
4. Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine. Hausen B, Boeke K, Berry GJ, Segarra IT, Christians U, Morris RE. J Heart Lung Transplant; 1999 Feb 27; 18(2):150-9. PubMed ID: 10194039 [Abstract] [Full Text] [Related]
5. Oral efficacy of the macrolide immunosuppressant SDZ RAD and of cyclosporine microemulsion in cynomolgus monkey kidney allotransplantation. Schuurman HJ, Ringers J, Schuler W, Slingerland W, Jonker M. Transplantation; 2000 Mar 15; 69(5):737-42. PubMed ID: 10755519 [Abstract] [Full Text] [Related]
6. Early clinical experience with a novel rapamycin derivative. Nashan B. Ther Drug Monit; 2002 Feb 15; 24(1):53-8. PubMed ID: 11805723 [Abstract] [Full Text] [Related]
7. Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability. Hausen B, Ikonen T, Briffa N, Berry GJ, Christians U, Robbins RC, Hook L, Serkova N, Benet LZ, Schuler W, Morris RE. Transplantation; 2000 Jan 15; 69(1):76-86. PubMed ID: 10653384 [Abstract] [Full Text] [Related]
8. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative. Daniel C, Ziswiler R, Frey B, Pfister M, Marti HP. Exp Nephrol; 2000 Jan 15; 8(1):52-62. PubMed ID: 10644883 [Abstract] [Full Text] [Related]
9. Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin. Hausen B, Gummert J, Berry GJ, Christians U, Serkova N, Ikonen T, Hook L, Legay F, Schuler W, Schreier MH, Morris RE. Transplantation; 2000 Feb 27; 69(4):488-96. PubMed ID: 10708100 [Abstract] [Full Text] [Related]
10. Chemical modification of rapamycin: the discovery of SDZ RAD. Sedrani R, Cottens S, Kallen J, Schuler W. Transplant Proc; 1998 Aug 27; 30(5):2192-4. PubMed ID: 9723437 [No Abstract] [Full Text] [Related]
11. Successful treatment of acute, ongoing rat lung allograft rejection with the novel immunosuppressant SDZ-RAD. Hausen B, Boeke K, Berry GJ, Christians U, Schüler W, Morris RE. Ann Thorac Surg; 2000 Mar 27; 69(3):904-9. PubMed ID: 10750781 [Abstract] [Full Text] [Related]
12. Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment. Hausen B, Boeke K, Berry GJ, Segarra I, Benet LZ, Christians U, Morris RE. Transplantation; 1999 Apr 15; 67(7):956-62. PubMed ID: 10221478 [Abstract] [Full Text] [Related]
13. The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation. Böhler T, Waiser J, Budde K, Lichter S, Jauho A, Fritsche L, Korn A, Neumayer HH. Transplant Proc; 1998 Aug 15; 30(5):2195-7. PubMed ID: 9723438 [No Abstract] [Full Text] [Related]
14. Isolation from pig liver microsomes, identification by tandem mass spectrometry and in vitro immunosuppressive activity of an SDZ-RAD 17,18,19,20,21,22-tris-epoxide. Lhoëst GJ, Gougnard TY, Verbeeck RK, Maton N, Dehoux JP, Wallemacq P, Schüler W, Latinne D. J Mass Spectrom; 2000 Mar 15; 35(3):454-60. PubMed ID: 10767777 [Abstract] [Full Text] [Related]
15. The macrolide SDZ RAD is efficacious in a nonhuman primate model of allotransplantation. Schuurman HJ, Schuler W, Ringers J, Jonker M. Transplant Proc; 1998 Aug 15; 30(5):2198-9. PubMed ID: 9723439 [No Abstract] [Full Text] [Related]
16. The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphates. Serkova N, Litt L, Leibfritz D, Hausen B, Morris RE, James TL, Benet LZ, Christians U. Br J Pharmacol; 2000 Feb 15; 129(3):485-92. PubMed ID: 10711346 [Abstract] [Full Text] [Related]
18. In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin. Crowe A, Lemaire M. Pharm Res; 1998 Nov 15; 15(11):1666-72. PubMed ID: 9833985 [Abstract] [Full Text] [Related]
20. Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RAD. Kirchner GI, Winkler M, Mueller L, Vidal C, Jacobsen W, Franzke A, Wagner S, Blick S, Manns MP, Sewing KF. Br J Clin Pharmacol; 2000 Nov 15; 50(5):449-54. PubMed ID: 11069439 [Abstract] [Full Text] [Related] Page: [Next] [New Search]